Page 67 - Cap Ltd News Today

Check-Cap (NASDAQ:CHEK – Get Rating) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report released on Monday, Zacks.com reports. The brokerage presently has a $0.50 price target on the medical research company’s stock. Zacks Investment Research‘s price target would indicate a potential upside of 30.34% from the […]

Investegate announcements from Tremor International, Transaction in Own Shares

Investegate announcements from InnovaDerma PLC, Form 8 (OPD) - InnovaDerma plc

Investegate announcements from K3 Bus Tech Grp PLC, Director/PDMR Shareholding

Investegate announcements from Poolbeg Pharma PLC, Distribution in Specie Shareholders

Investegate announcements from Grit Real Estate Inc, Update on proposed acquisition of majority stakes

Investegate announcements from Tremor International, Tremor & Comscore - Programmatic CTV Partnership

Investegate announcements from Elixirr Intnl PLC, Director/PDMR Shareholding

Investegate announcements from Savannah Resources, Board Changes

/PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the...